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ABSTRACT 
CLICK SCAFFOLDS FOR THE INHIBITION OF PORPHYROMONAS GINGIVALIS 
AND STREPTOCOCCUS GORDONll BIOFILM FORMATION 
Catherine M. Loner 
April 18,2012 
Periodontitis and its systemic sequelae remain a major public health problem and 
developing a cost-efficient therapy will benefit healthcare worldwide. Adherence of 
Porphyromonas gingivalis to Streptococcus gordonii facilitates colonization ofthe oral 
cavity by P. gingivalis and contributes to development of periodontal disease. It has been 
demonstrated that synthetic peptides (BAR-peptides) inhibit this interaction and the 
formation of P. gingivalis biofilms. However, peptides are susceptible to proteolytic 
degradation thereby precluding their use as therapeutic agents. Consequently, rationally-
designed small-molecule peptidomimetics of BAR will potently inhibit P. gingivalis 
adherence to S. gordonii and represent viable therapeutic compounds. In terms of 
inhibitor design, a small molecule "click" strategy was employed whereby the azide-
bearing partner constitutes a trisubstituted oxazole framework and the terminal acetylene 
partner constitutes a 5-ethynylmethylene-l ,3-diaminotriazine framework. The design, 
synthesis and chemistry of the coupling partners in both the acetylenic and azido series 
have been developed, and the use of these compounds as therapeutic agents is discussed. 
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Significance of Periodontal Diseases 
Periodontal disease is one of the most common bacterial infections in humans. 
The World Health Organization estimates that severe periodontitis, defined as having 
sUbgingival pocket depths of greater than or equal to 6mm, occurs in 5-20% of adults 
worldwid I When individuals with milder forms of the disease (i.e. pocket depths of 4-5 
mm) are included, the prevalence of periodontitis increases to approximately 35-50% of 
the adult population I . In the United States alone, the annual expenditure for the treatment 
of periodontal diseases is in the billions of dollars2• Not only is periodontitis alone a 
prevalent health issue, but it has also been linked to other systemic illnesses such as 
respiratory diseases, adverse pregnancy outcomes, chronic renal disease, oral cancer, 
Inflammatory Bowel Disease, and Alzheimer Disease3. The most common treatment for 
periodontal diseases is scaling and root planing, which is the clinical removal of soft and 
hardened subgingival biofilms from exposed root surfaces with the use of specific 
dentistry tools4• The other commonly used therapy is periodontal surgery. The benefits 
of periodontal surgery over scaling and root planing is that surgery allows for better 
access for cleaning of the root surfaces, pocket reduction (or elimination) and exposure of 
root surfaces for proper cleaning by the patients4• These therapeutic approaches are 
efficient for removing the bacteria, however these approaches do not specifically target 
periodontal pathogens nor do they prevent or limit re-colonization of the oral cavity by 
these pathogens after removal. Therefore, the initial colonization mechanisms utilized by 
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P. gingiva/is are analyzed in this study and are viewed as important targets for the 
development of therapeutic agents. As discussed below, interfering with P. gingivalis 
adherence to S. gordonii may block initial colonization of the supragingival biofilm by 
the organism and prevent it from reaching and multiplying in its primary niche in the 
sUbgingival plaque. 
Periodontal Diseases: Significance of the P. gingivalis-S. gordon;; interaction 
The bacterial etiology of periodontal disease is complex, and a variety of 
organisms have been associated with the initiation and progression of the disease. Many, 
if not all, of these organisms may also be present in healthy individuals, albeit at lower 
levels than in the disease state, and can exist in mutual harmony with the host. Thus, 
disease episodes develop from a shift in the ecological balance between bacterial and host 
factors. For example, alteration in the absolute or relative numbers of certain organisms, 
or alteration of particular host factors could shift the ecological balance towards disease5• 
In general, severe forms of the disease in adults are associated with a limited 
number of gram-negative anaerobic bacteria. Within this group, evidence points to a 
pathogenic role for P. gingivalis, and the presence of this organism appears to be 
essential for disease activity. In addition, the results of a study completed by 
Hajishengallis et. a1.6 showed that the presence of P. gingiva lis in the oral cavity, even at 
low levels, caused significant changes in the oral biofilm that were associated with 
inflammation and ultimately, the resorption of alveolar bone. Specifically, this study 
demonstrated that the introduction of P. gingiva/is into specific-pathogen-free mice led to 
the elevation of commensal bacterial popoulations and also changed the composition of 
the murine oral microbiota. Importantly, as determined by real-time peR, P. gingiva lis 
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represented <0.01% of the total bacteria count in the biofilm6 . Even at such a low levels, 
P. gingivalis caused significant disruption of host-microbe homeostasis resulting in a 
shift from a non-pathogenic to a pathogenic community6. Thus, if the initial attachment 
of P. gingivalis to the oral tissue surfaces or to antecedent bacteria can be prevented, it 
may be possible to control P. gingivalis populations and maintain host-microbe 
homeostasis5. 
The oral cavity provides a variety of surfaces like the mineralized hard tissues of 
the teeth, the mucosal surfaces of the gums, the cheek, and the tongue to which P. 
gingivalis can adhere. Colonization of surfaces remote from the gingival crevice and 
periodontal pocket can still have significance for the disease process because once 
established, P. gingivalis may reach the subgingival area by spreading proliferation or by 
the movement of detached bacteria into the area5• Oral surfaces generally are coated with 
a pellicle composed predominantly of salivary molecules. It is components of these 
pellicles that function as receptors for primary colonizer bacterial adherence. The oral 
surfaces rapidly become colonized with the early commensal microbiota of the mouth, as 
a consequence, organisms such as P. gingivalis usually encounter surfaces rich in 
antecedent bacteria and their products5 . P. gingivalis can adhere to many of these early 
plaque organisms such as oral streptococci, specifically S. gordonii, and use their 
metabolic products as nutrients for growth and proliferation. 
P. gingivalis contains two types of fimbriae and other outer membrane proteins 
which allow it to bind to bacterial substrates in the oral cavit/. Specifically, the 
adhesion of P. gingiva/is and S. gordonii is multi modal and involves at least two distinct 
receptor-ligand pairs. The long and short fimbriae of P. gingivalis have both been shown 
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to be involved in this interaction8. The structural subunit of the long fimbriae, FimA, has 
been shown to interact with cell surface glyceraldehyde-3-phosphate dehydrogenase 
(Gap-DB) of S. gordonii9, 10, whereas the minor fimbrial protein, Mfal, interacts with 
streptococcal SspB II , a cell surface protein in the antigen IIII family that is expressed by 
virtually all of the oral streptococci 12 . Interestingly, although virtually all of the oral 
streptococci express antigen VII, P. gingiva/is selectively adheres to S. gordonii and the 
related oralis group of streptococci? This suggests that P. gingivalis selectively 
colonizes S. gordonii and the related oralis streptococci over the mutans streptococci. In 
addition, Demuth et. al.13 and Cook et. al. 14 showed that the Mfal-SspB interaction is 
essential for the development of P. gingivalis biofilms on a streptococcal substrate and 
that biofilm growth exhibits the same selectivity for streptococcal species. 
Important Findings in Previous Studies 
As discussed above, two fimbrial proteins of P. gingivalis (FimA and Mfal) 
interact with specific receptors of S. gordonii (GapDB and SspB) and the Mfal-SspB 
interaction is essential for the adherence of intact P. gingivalis to streptococcal cells and 
the subsequent development of P. gingivalis biofilms13, 14. Structure-function analyses on 
the mechanism of Mfal-SspB interaction identified a discrete region of SspB, designated 
BAR (SspB Adherence Region) that was essential for the association of P. gingiva/is 
cells with S. gordonii. Daep et. al.? showed that a synthetic peptide encompassing the 
active site region of SspB is a potent inhibitor (50% inhibitory at a concentration of 1.3 
).lM) of P. gingiva/is adherence to S. gordonii cells and blocks the formation of P. 
gingivalis biofilms? This peptide is also capable of disrupting existing P. gingivalis 
biofilms (D.R. Demuth, unpublished). Two structural motifs in BAR, NITVK and 
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KKVQDLLKK7, 15 were shown to be the active motifs contributing to P. gingivalis 
adherence. When each of these amino acid sequences separately was tested for inhibitory 
activity, they were inactive, which confinned that the interaction of BAR with P. 
gingivalis requires both the KKVQDLLKK and NITVK motifs l5 . 
Several structure and functional analyses have been done on the BAR peptide that 
have given many insights into the characteristics that make the S. gordonii-P. gingiva lis 
. . . I d b D I 7 h . 'd A 1182 Thr1184 d mteractIOn umque. n a stu y y aep et. a. t e ammo aCI s sn, , an 
Val1l85 of the NITVK sequence were replaced with each of the other 19 common amino 
acids, and the resulting substituted peptides were tested to detennine their inhibitory 
activity. This study showed that peptides containing positively charged amino acids 
replacing Asn 1182 or bulky hydrophobic residues replacing Val 1185 increased the binding 
of P. gingivalis to the BAR peptide. These positive replacements suggest that both 
electrostatic and hydrophobic interactions are important for Mfal-SspB binding7. It was 
also shown that replacement of Asn1182 or Val 1185 with Pro or Gly residues decreased the 
interaction between P. gingivalis and BAR. Since these amino acids are helix disrupting, 
this result suggested that the secondary structure of BAR is also important for activit/. 
A subsequent study by Daep et. al. 15 showed that the second active motif, 
KKVQDLLKK, along with the NITVK motif have characteristics that are similar to the 
eukaryotic nuclear receptor box protein-protein interaction domainl5 . The nucIear-
receptor box is a short, hydrophobic, alpha-helical motif in eukaryotic co-activator 
proteins (consensus LXXLL) that is essential for their interaction with the cognate 
nuclear receptorl6. This interaction is stabilized by hydrogen bonding and/or charge-
charge interactions of amino acids flanking LXXLLI7 with the ligand-binding domain of 
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the nuclear receptor I 6. To determine ifVXXLL in BAR functioned similarly to the 
nuclear-receptor box, Daep et. al. I5 examined the contribution of the alpha-helical 
content, the hydrophobic character ofVXXLL, and the contribution of charged amino 
acids flanking VXXLL to the interaction of BAR with P. gingiva/is. The alpha-helical 
content and the presence of basic residues were shown to playa greater role in the 
association of BAR with P. gingiva/is than did the hydrophobic character of the VXXLL 
alpha-helix, although this characteristic was still necessary for the interactionl5 . 
Why BAR peptide mimetics? 
The development of the BAR peptide and the modified BAR peptides that 
increase its inhibitory activity is a great advancement and forms the foundation to 
develop potential targeted therapies to limit P. gingivalis infections. However, the use of 
peptides as therapeutics has limitations arising from the high cost of peptide synthesis 
and their susceptibility to proteases expressed by oral organisms, including P. gingivalis 
itself. The challenge is to produce a potent and stable inhibitor that is not based on a 
peptide backbone but mimics the natural peptide substrate recognized by Mfal. The 
aforementioned studies that have defined the physiochemical properties important in the 
Mfal-SspB interaction are important, and show specific characteristics that any 
developed chemical substrate should mimic in order to be a potent inhibitor. 
Role of Synthetic Click Chemistry 
One traditional alternative approach to identify a non-peptide based inhibitor of 
the Mfa-SspB interaction involves the synthesis and screening of large numbers of 
compounds to isolate the few functional inhibitors that the initial compound library may 
contain. However, this approach also has limitations since it is both costly and time 
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consummg. To overcome these limitations, we proposed to utilize a novel organic 
synthesis approach called in situ click chemistry to design and synthesize non-peptide 
based inhibitors of the Mfal-SspB interaction, using the structural and biochemical 
information of the Mfal-SspB interaction derived from previous work as a foundation. 
Click chemistry is a chemical philosophy introduced by K. Barry Sharpless in 
1999. Click chemistry is not a specific reaction, but a concept that mimics nature. It is 
chemistry tailored to generate substances quickly and reliably by joining small units 
together whereby the product may have greater activity than the individual fragments. 
This joining is inspired by the fact that nature also generates substances by combining 
smaller units together 1 8 • For example, proteins are made from repeating amino acid units 
and sugars are made from repeating monosaccharide units. The connecting units in click 
chemistry are based on carbon-hetero atom bonds (C-X-C) rather than C-C bonds 1 8. 
Sharpless and his group have defined a set of guidelines for a reaction to be considered 
click chemistry. "The reactions must be modular, wide in scope, give very high yields, 
generate only inoffensive bypro ducts that can be removed by non-chromatographic 
methods, and be stereo-specific. The required process characteristics include simple 
reaction conditions, readily available starting materials and reagents, solvent-less 
conditions or a solvent that is benign or easily removed, and simple product isolation 18." 
Furthermore, the reactions need to have a high thermodynamic driving force, greater than 
20 kcallmol is preferable. Having this high thermodynamic driving force will lead to a 
reaction that is quick, and selective for a single product 18. 
In this particular study, we have utilized the most common click chemistry 
reaction, the Huisgen 1 ,3-dipolar cycloaddition of azides and terminal alkynes to form 
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1,2,3-triazoles[l9]. Azides and acetylenes are highly energetic functional groups and the 
1 ,2,3-triazole fonnation from these two functional groups is a particularly powerful 
linking reaction due to its high degree of dependability and complete specificity. The 
following is an example of the simplest metal catalyzed mechanism for the cycIoaddition 
of azides and tenninal alkynes to fonn triazoles (Figure 1)1 9. 
a , 
1--0 
~_ J , 
----': ~ . L XL J. 
"'l'· 
l 
Additionally, Figure 2 is the basic click reaction that was utilized in this study, and the 
triazole product that this reaction produces is more than just a passive linker. The 
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With the philosophy of in situ click chemistry as a guide and the use of the 
azide/acetylene coupling reaction, our study is a target-guided synthesis that utilizes a 
8 
biologic target (in this case, the Mfal protein) as a scaffold to select reactive chemical 
precursors and assemble potent inhibitors from these reactive building blocks within the 
confines of its own active site. Essentially, the Mfal protein will function as a template 
for the synthesis of its own inhibitors. The activity of compounds that are catalyzed by 
Mfal can then be assessed using a variety of already established in vitro assays, including 
protein binding assays, bacterial adherence assays and dual species biofilm cultures. 
Ultimately, active compounds can be tested for in vivo efficacy using a mouse model of 
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RESULTS 
The BAR peptide analogs were designed based from direct molecular modeling 
approaches of the VQDLL and NITVK motifs of the BAR region of the S. gordonii SspB 
protein and the recent 3D structure of the C-terminal domain of SSpB21. The syntheses of 
the compounds utilized basic scaffolds applied in pharmacophore design and are 
amenable to scale-up if considerable quantities are required for extensive analog 
synthesis and bioassays. 
Using Gaussian 2003 Program Suite and Visual Molecular Dynamics (VMD) 
software, the VQDLL sequence was viewed in a 3-Dimensional ball-and-stick image 
(Figure 2). From this image, it was discovered that the VQDLL motif has an 
arrangement of an equilateral triangle shape when viewed "head-on." The points of the 
triangle fall on the central alkane carbons of the two Leucine residues and the Valine 
residue (Figure 3). 
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In the designing of the small molecule mimics for the VQDLL sequence, the approach 
was to put hydrophobic appendages on a triazine core scaffold to mimic the Vall 174 and 
Leul177-78 residues in the VQDLL sequence. The hydrophobic appendages of this 
molecule will be able to insert deep into the hydrophobic groove of the BAR/Mfal 
interaction, while the triazine central scaffold is the mimic for the helix backbone which 
is outside the hydrophobic groove. Also attached to the core scaffold was the essential 
"click" component, a terminal acetylene functional group. 
Specifically, the acetylene-bearing component utilized the symmetrical triazine as 
the central scaffold with isobutylamine appendages to mimic the Leu 1177 and Leu 1178 side 
chains in the VQDLL motif. The readily available cyanuric chloride (24) was reacted 
with trimethylsilylacetylene, n-butyllithium, in THF (Scheme 7), which provided the 
acetylene dichlorotriazine (26). Substitution of the two remaining chlorides was 
accomplished with isobutylamine to give the triazine-based inhibitor shown (28). 
Although currently only one triazine based inhibitor has been developed, the length of the 
acetylenic side chain can be varied as to provide the best mechanics for the click reaction. 
Similarly, the isobutyl amine appendages can be lengthened and varied to optimize 
binding in the hydrophobic pocket of the Mfal interaction. 
The design of the NITVK-motifBAR inhibitor peptide mimetics used an oxazole 
as the core scaffold structure. Attached to the oxazole core were two phenyl rings 
extending from the 4 and 5 carbons. As mentioned in the introduction, a previous study 
found that amino acids containing hydrophobic phenyl groups, Tryptophan and 
Phenylalanine, that were substituted in the Val l185 position of the NITVK sequence 
increased inhibition of the BAR peptide 7. This suggested that residues in the 1185 
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position may be accommodated by a hydrophobic pocket in Mfal. Thispositive 
substitution was the basis as to why two hydrophobic phenyl groups were chosen to be 
attached to the core oxazole. The two phenyls substituted on the oxazole will ideally fit 
into the hypothesized hydrophobic pocket of the Mfal protein and mimic the Val l185 and 
the closely positioned Ile l183 residue in the NITVK motif. Furthermore, the diphenyl 
oxazole was chosen because of the inexpensive starting material, benzoin. Many 
different esters could be created using benzoin as a starting material. 
Five total azide oxazole precursor molecules have been created with variations on 
the 2-carbon azide side chain. The first variation was the number of carbons in the azide 
alkyl chain. Varying the length of this hydrocarbon varies the length between the triazine 
click partner and the hydrophobic phenyls attached the oxazole. Testing these three 
molecules will show whether one distance is more inhibitory than another distance, and 
thus help provide more information for optimizing the lead compound. In addition, 
positioning the azide in the para- and meta- positions attached to a phenyl group varies 
the angle between the triazine and the phenyl appendages of the oxazole. One angle 
might be more inhibitory than the other and will provide yet another clue into the 
preference Mfal has for the click molecule. 
The oxazole compounds were prepared by a cyclization reaction (Schemes 2-6). 
Two methods were used to prepare benzoin ester intermediates that were then cyclized 
into the oxazole: Benzoin, triethylamine, DMAP, dichloromethane, and the acid chloride 
at O°C (Schemes 3 & 4) and benozin, acid chloride, and pyridine at O°C (Schemes 2, 5, 
6). Both methods were utilized depending on the type of acid chloride used. Two 
methods were also utilized for the cyclization of the benzoin esters to the oxazole. 
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Thiourea in N,N-dimethylformamide (Scheme 1). This method worked for all benzoin 
esters that did not contain an azide group or bromine, but did possess groups, which 
could be transformed to azides. However, when attempted on the benzoin esters with an 
azide group, this method did not give product, presumably due to reductive 
decomposition. Method 2: The benzoin ester combined with ammonium acetate in 
glacial acetic acid at 118-120DC (Scheme 2-6). This method of cyclization was less 
reactive than the thiourea method, and was capable of cyclizing the azide benzoin esters 
as well as the esters not containing an azide at approximately the same temperatures. 
An example of the future click cycloaddition reaction between the oxazole-
scaffold azide molecule and the triazine-scaffold acetylene molecule is detailed in 
Scheme 8. The terminal acetylenes are very reactive toward alkyl or aroyl azides giving 
1,2,3-triazoles. This reaction is self-contained and requires no additional reactants, 
catalysts, or byproducts. When the coupling partners are incubated in the presence of the 
Mfa1 protein, a thermal cycloaddition reaction should ensue, and under favorable binding 
conditions should afford the coupled product triazole. However, if this method of using 
the Mfa1 protein as the catalyst does not give the result desired, other catalysts will be 
attempted, and the click scaffolds will be combined outside of a biological environment. 
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METHODS 
Solvents and reagents were ACS grade and used as commercially supplied. 
Tetrahydrofuran was distilled from a mixture of sodium and benzophenone prior to its 
use. Analytical thin-layer chromatography (TLC) utilized 0.25 mm pre-cut glass-backed 
plates (Merck, Silica Gel 60 F254). Thin-layer chromatograms were visualized during 
chromatographic and extraction runs by rapidly dipping the plates m 
anisaldehyde/ethanollsulfuric acid stain or phosphomolybdic acid/ethanol stain and 
heating (hot plate). Column chromatography was carried out using silica gel 60 (E. 
Merck 9385, 235-400 mesh/flash) or silica gel 62 (Mallinckrodt 6551, 60-200 
mesh/gravity). Melting points were taken on a Thomas Hoover apparatus. Extracts and 
chromatographic fractions were concentrated with a Biichi rotavapor under water 
aspirator vacuum. Nuclear magnetic resonance eH and l3C NMR) spectra were recorded 
with Varian INOVA 500 or VNMRS 400 instruments using CDCh as a solvent and 
internal standard. Infrared spectra (Fourier transform infrared spectroscopy, FTIR) were 
recorded with a Perkin-Elmer Spectrum 100 instrument. 
2-0xo-l,2-diphenylethyl acetate (2): Benzoin 1 (2.0 g, 9.40 mmol) was dissolved in 
acetic anhydride (I5 mL, 158.70 mmo]) followed by the addition of two drops of sulfuric 
acid which resulted in a pale yellow color. The reaction mixture was then stirred under a 
nitrogen atmosphere at room temperature (72h) while monitoring its progress by TLC. 
The reaction mixture was then dissolved in water and extracted with dichloromethane (3 
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x 40mL). The dichloromethane layer was then dried over anhydrous sodium sulfate. 
After removal of the drying agent by filtration and removal of the solvent by rotary 
evaporation, the product was found to be of acceptable purity as evidenced by IH NMR 
and TLC, Rf: 0.2 (hexane/ethyl acetate, 2:1): mp 83-85°C (Lit.22 85-87°C) 
2-Methyl-4, 5-diphenyloxazole (3): 2-0xo-1 ,2-diphenylethyl acetate 2 (0.20g, 0.79 
mmol) was dissolved in DMF (10 mL). Thiourea was then added and the reaction was 
refluxed (160°, oil bath) under nitrogen atmosphere. As the reaction progressed, the color 
changed from colorless to a light yellow-orange and had an odorous smell. The reaction 
was monitored by TLC and when complete, the reaction mixture was dissolved in 
dichloromethane (40 mL) and then washed with water (3 x 30 mL). The 
dichloromethane layer was separated and dried over anhydrous sodium sulfate. Removal 
of the drying agent by filtration and rotary evaporation of the solvent gave a crude oil that 
was purified by flash chromatography on silica gel (dichloromethane) to provide 3 
(74%): Rf: 0.098 (hexane/ethyl acetate, 2:1); FTIR 2920.50; 1220.30; 1502.00, 1588.24 
cm-I; IH NMR (400 MHz, CDCh) 8: 2.617 (s, 3H); 7.25-7.66 (m, 10H, aromatic); I3C 
NMR (l00 MHz, CDCl3) 8160.35, 145.41, 134.82, 126.46-132.14, 13.92 
General Procedure for the Preparation of Benzoin Esters (4a, 4b, 4c): Benzoin (leq) 
was dissolved in pyridine (10 mL) followed by cooling the solution to O°C (ice water 
bath). The aroyl chloride (leq, benzoyl chloride, 4-bromobenzoyl chloride, 4-
nitrobenzoyl chloride) was then added dropwise to the stirred solution while cooling. 
The reaction flask was then capped, and after stirring 30 minutes, the cooling bath was 
removed. The reaction mixture was stirred (l8h) while monitoring by TLC. After the 
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starting materials were consumed, the reaction mixture was dissolved in dichloromethane 
(l50 mL) and washed with 5% aqueous HCI (5 x 100 mL). The organic layer was then 
separated and dried over anhydrous sodium sulfate. Flash chromatography on silica gel 
(hexane/ethyl acetate, 9:]) afforded esters 4a, 4b and 4c as crystalline solids in 87%, 32% 
and 45% yield respectively. 2-oxo-l,2-diphenylethyl benzoate (4a): m.p. 123-] 26°C 
(Lit.23 125-126°C) 2-oxo-] ,2-diphenylethyl-4-bromobenzoate (4b): mp. 126-128°C 
(Lit.24 126-127°C). 2-0xo-l,2-diphenylethyl-4-bromobenzoate (4c): Rf: 0.24 
(hexane/ethyl acetate, 9:1); FTIR 1708.25, 1690.56, 1498.22, 1449.91 cm-I; IH NMR 
(400 MHz, CDCh) 8: 7.13 (s, 1H); 7.36-8.04 (m, 14H); I3C NMR (100 MHz, CDCh) 8: 
193.45, 165.35, 128.37-134.6], 78.22 
General Procedure for the Preparation of Triaryl Oxazole Formation (Sa, Sb, Sc): 
The benzoin ester (1 eq, 4a, 4b, 4c) is dissolved in glacial acetic acid (8 mL). 
Ammonium acetate (15 eq) was then added and the reaction mixture was refluxed 
(l18°C, oil bath) under nitrogen (1.5h). The reaction was monitored by TLC and when 
complete, the reaction mixture was dissolved in diethyl ether (200 mL) and washed with 
6% aqueous sodium hydroxide solution (4 x 100 mL). The dichloromethane layer was 
then separated and dried over anhydrous sodium sulfate. Removal of the drying agent by 
filtration and rotary evaporation of the solvent gave a crude oil that was purified by flash 
chromatography on silica gel (hexane/ethyl acetate, 9: 1) to furnish the triaryl oxazoles Sa 
(31 %, mp 116-118°C, Lit.25 116-117°C), Sb (14%, mp 144-145°C; Lit.26 145-146°C) and 
Sc in 31%, 14%, and 5% yield respectively. 2-(4-Bromophenyl)-4,S-diphenyloxazole 
(5c): Rf: 0.52 (hexane/ethyl-acetate, 9:1); FTIR 116l.00, 1475.00, 1605.12 cm-l; IH 
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NMR (400 MHz, CDCb) 8: 7.416-8.06 (m, 14H); l3 C NMR (100 MHz, CDCb) 8: 
lS9.26, 14S.87, 136.87, 124.93-132.29" 
General Procedure for the preparation of 3- and 4-azidobenzoic acid (7, 12): The 3-
amino- or 4-aminobenzoic acid (I eq) was dissolved in 10% aqueous HCI solution and 
cooled to O°C (ice bath). Aqueous sodium nitrite (1.1 eq, 20%) was then added and the 
reaction mixture was allowed to stir at room temperature (1S min). An 20% aqueous 
solution of sodium azide (1.2 eq) then was added at room temperature which resulted in a 
vigorous reaction and creating a foaming precipitate which filled the headspace of the 
reaction flask. The foam precipitate, which was the azidobenzoic acid product, was 
collected by vacuum filtration while washing the filter cake with water and excess 
solvent was removed by rotary evaporation. The slightly yellow-white solids 4-Azido 
Benzoic Acid: mp 189-190°C, Lit.27 188.S-190°C and 3-Azido Benzoic Acid: mp 176-
178°C, Lit.28 176-177°C were of sufficient purity to use in the next step. 
General Procedure for the Preparation of 3- and 4-azidobenzoyl chloride (8, 13): 
The azidobenzoic acid 7 or 12 (1 eq) was dissolved in thionyl chloride (4.Seq). The 
mixture is heated to reflux (7S0C), and allowed to stir (Sh). The reaction mixture was 
then allowed to stir overnight at room temperature. Thionyl chloride was then removed 
by adding dichloromethane (1 OmL) and concentrating with the rotary evaporator under 
aspirator vacuum. The addition of dichloromethane and vacuum rotary evaporation was 
repeated (3X) to give the acid chloride as an oil. The azidobenzoyl chloride was used in 
esterification step without further purification. 
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General Procedure for the Preparation of 2-oxo-l,2-diphenylethyl-3-azidobenzoate 
(9) and 2-oxo-l,2-diphenylethyl-4-azidobenzoate (14): Benzoin (leq), triethylamine 
(l eq), and 4-dimethylaminopyridine (0.1 eq) are dissolved in dichloromethane (lO mL) at 
ODC (ice water bath). The azidobenzoyl chloride (l eq ) in dichloromethane (5mL) is 
gradually introduced into the reaction flask while stirring. The reaction mixture was 
allowed to stir (3h) at room temperature while monitoring by TLC. Upon completion of 
the reaction as evidenced by TLC, the reaction mixture was dissolved in diethyl ether 
(100 mL) and washed with 5% aqueous HCI solution (4 x 50 mL) followed by 5% 
aqueous sodium bicarbonate (2 x 100mL). The organic layer was separated and dried 
over anhydrous sodium sulfate. Removal of the drying agent by filtration and rotary 
evaporation of the solvent gave a crude solid that was purified by flash chromatography 
on silica gel (hexane/EtOAc, 4:1) to obtain 9 and 14 in 72% and 80% yield. 2-oxo-l,2-
diphenylethyl-4-azidobenzoate (9): Rf: 0.42 (hexane/ethyl acetate, 4: 1); FTIR 
2118.00, 1174.79, 1710.42, 1693.73, 1448.18, 1504.39 cm-I; IH NMR: (400MHz, 
CDCh) 0: 6.96 (s, IH); 6.99-7.33 (m, 14H); 7.90-7.92 (d, 2H, J=7.99); 8.01-8.04 (d, 2H); 
I3C NMR (lOOMHz, CDCh) 0: 193.62, 165.20, 145.29, 118.81-145.20,78.06_ 2-oxo-
1,2-diphenylethyl-3-azidobenzoate (14): Rf: 0.53 (hexane/ethyl acetate, 4:1); FTIR 
2124.85, 1299.51, 1711.90, 1695.45, 1482.43, 1448.61 cm-I; IH NMR: (400MHz, 
CDCh) 0: 7.00 (s, IH); 7.08-7.90 (m, 14H); I3C NMR (l00 MHz, CDCh) 0: 193.42, 
165.20,120.16-140.62,78.33 
General Procedure for the Preparation of 2-(3-azidophenyl)-4,5-diphenyloxazole 
(10) and 2-(4-azidophenyl)-4,5-diphenyloxazole (15): The azido benzoic esters 9 or 14 
(l eq) and ammonium acetate (l5 eq) are combined in glacial acetic acid (l0 mL). The 
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mixture is allowed to react at reflux (118°C) for 2 hours under an atmosphere of nitrogen. 
The reaction mixture was monitored by TLC and when complete, the reaction mixture 
was dissolved in diethyl ether (110 mL) and washed with NaOH solution (3 x 100mL). 
The diethyl ether layer is separated and dried over anhydrous sodium sulfate. Removal 
of the drying agent by filtration and rotary evaporation of the solvent gave a crude oil that 
was purified by flash chromatography on silica gel (hexane/ethylacetate, 4: 1) to obtain 10 
and 15 in 61 % and 80% yield. 2-(4-azidophenyl)-4,5-diphenyloxazole (10): Rf: 0.60 
(hexane/ethyl acetate, 4:1); FTIR: 2088.97,1278.93,1608.72,1493.77,1087.95 em-I; IH 
NMR: (500 MHz, CDCh) 7.21-8.13 (m, 14H, aromatic); I3C NMR (125 MHz, CDCh) 0: 
159.46, 145.61, 142.26, 136.47, 119.34-132.01 2-(3-azidophenyl)-4,5-diphenyloxazole 
(15): Rf: 0.53 (hexane/ethyl acetate, 4:1); FTIR: 2146.37,1276.93,1590.12,1590.35 cm-
I; IH NMR: (400 MHz, CDCh) 0: 7.09-7.94 (m, 14H, aromatic); I3C NMR (100 MHz, 
CDCh) 0: 159.09, 145.96, 140.87, 136.85, 116.84-132.25. HRMS 
General Procedure for the Preparation of Acid Chlorides (16a, 16b): 5-
Bromovaleric acid (1 eq) or 4-bromobutyric acid (1 eq) was dissolved in thionyl chloride 
(4.5 eq). The reaction mixture was then refluxed (75°C, oil bath) under nitrogen 
atmosphere overnight. The excess thionyl chloride was removed by adding 
dichloromethane (25 mL) and removing using a rotary evaporator under aspirator 
vacuum. The addition of the dichloromethane and rotary evaporation was repeated (3x) 
which yielded the acid chloride as an oil. The 5-bromovaleryl chloride 16a or the 4-
bromo butyryl chloride 16b were used without further purification in the next step. 
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General Procedure for the Preparation ofthe Bromoacyl Esters (17a, 17b): Benzoin 
(1 eq) was dissolved in pyridine (l2 mL) followed by cooling the solution to O°C (ice 
water bath). The acid chloride 16a or 16b (l eq) was then added dropwise to the stirred 
solution while cooling. The reaction flask was capped, and after 30 minutes, the cooling 
bath was removed. The reaction mixture was stirred (4h) while monitoring by TLC. 
After the starting materials were consumed, the reaction mixture was then dissolved in 
dichloromethane (300 mL) and washed with 5% aqueous HCI (5 x 120 mL). The organic 
layer was then separated and dried over anhydrous sodium sulfate. Flash 
chromatography on silica gel (hexane/ethyl acetate, 6: 1) afforded esters 17a and 17b as 
oils in 70% and 23% yield respectively: 2-0xo-l,2-diphenylethyl-4-bromobutanoate 
(17a): Rf: 0.49 (hexane/ethyl acetate, 4: 1); FTIR: 3063.60, 1708.60, 1692.03, 1588.70, 
1531.70 cm· l ; IH NMR (400 MHz, CDCb) 8: 2.21-2.23 (t, 2H); 2.60-2.69 (m, 2H); 3.45-
3.47 (t, 2H); 6.85 (s, IH); 7.28-8.01 (m, 10H); I3C NMR (l00 MHz, CDC b) 8: 193.66, 
172.08, 134.56, 133.57, 128.70-129.43, 77.85, 32.55, 32.34, 27.83 2-oxo-l,2-
diphenylethyl-5-bromopentoate (17b): Rf: 0.47 (hexane/ethyl acetate, 4: 1); FTIR: 
1734.38,1693.88,1597.38,1448.37 cm· l ; IH NMR (400MHz, CDCb) 8: 1.81-1.87 (m, 
2H); 1.91-1.98 (m, 2H); 2.44-2.59 (m, 2H); 3.40-3.43 (t, 2H); 6.85 (s, IH), 7.35-7.93 (m, 
10H); I3C NMR (100MHz, CDCh) 8: 193.75, 172.63, 134.59, 133.49, 128.07-128.83, 
60.25,44.55,33.09,31.76,23.38. 
General Procedure for the Conversion of the Brominated Esters 17a, 17b to Azido 
Esters (18a, 18b): The halogenated ester 17a or 17b (leq) was dissolved in DMF. 
Sodium azide (1.1 eq) was then added and the reaction mixture was refluxed (80°C, oil 
bath) under a nitrogen atmosphere (4h). The reaction mixture was monitored by TLC 
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and when complete, the DMF was removed under high vacuum. The crude oil was 
purified by flash chromatography on silica gel (hexane/ethylacetate, 9: 1) to obtain 18a 
and 1Sb in 85% and 56% yield respectively: 2-oxo-l,2-diphenylethyl-4-azidobutanoate 
(18a): Rf: 0.44 (hexane/ethylacetate, 4:1); FTIR: 2096.16, 1448.47, 1734.69, 1693.83, 
1580.74, 1496.07 em-I; IH NMR (500MHz, CDCh) 0: l.82-l.92 (t, 2H); 2.41-2.60 (m, 
2H); 3.28-3.38 (t, 2H); 6.82 (s, 1H); 7.25-7.98 (m, 10H, aromatic); l3C NMR (l25MHz, 
CDCh) 0: 193.65,172.23,134.55,133.56,128.69-129.19,77.86, 50.54, 30.95, 24.33. 2-
oxo-1,2-diphenylethyl-5-azidopentanoate (18b): Rf: 0.22 (hexane/ethyl acetate, 4:1); 
FTIR2092.58, 1224.81, 1734.84,1694.21,1597.46,1448.81 em-I; IHNMR: (500 MHz, 
CDCh) 0: 1.52-1.61 (m, 2H); 1.62-l.71 (m, 2H); 2.32-2.49 (m, 2H); 3.14-3.22 (t, 2H); 
6.782 (s, 1H); 7.24-7.85 (m, lOH); l3C NMR (125 MHz, CDCh) 0: 193.76, 172.64, 
134.60,133.55,128.66-129.36,77.66,51.02,33.33, 28.13, 22.04. 
General Procedure for the Preparation of the Azidoalkyl Oxazoles (19a, 19b): The 
azido ester 18a, 1Sb (1 eq) was dissolved in glacial acetic acid (10 mL). Ammonium 
acetate (15 eq) was then added and the reaction mixture was refluxed (118°C, oil bath) 
under a nitrogen atmosphere (2h). The reaction mixture was monitored by TLC, and 
when complete as evidenced by the disappearance of the ester, the reaction mixture was 
dissolved in diethyl ether (100 mL) and washed with aqueous sodium hydroxide (3 x 100 
mL). The organic layer was separated and dried over anhydrous sodium sulfate. Flash 
chromatography on silica gel (hexane/ethylacetate, 8: 1) afforded 19a and 19b in 64% and 
81 % yield; 2-(3-azidopropyl)-4,5-diphenyloxazole (19a): Rf: 0.30 (hexane/ethylaeetate, 
8:1); FTIR 2094.21,1218.91,2933.26,1570.34,1501.98,1218.91 em-I; IH NMR: (500 
MHz, CDCh) 0: 2.16-2.19 (m, 2H); 3.02-3.06 (t, 2H); 3.49-3.51 (t, 2H); 7.35-7.67 (m, 
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10H); DC NMR (1 25MHz, CDCb) 8: 162.68, 145.69, 134.22, 126.54-131.34, 50.55, 
26.31, 25.18. 2-(4-azidobutyl)-4,S-diphenyloxazole (19b): Rf: 0.50 (hexane/ethyl 
acetate, 4:1); FTIR 2936.78,2091.06, 1218.94, 1570.01, 1501.95, 1157.14 cm· l ; IH 
NMR: (500 MHz, CDCI3) 8: 1.77-1.80 (m, 2H); 1.96-2.0 (m, 2H); 2.92-2.95 (t, 2H); 
3.36-3.39 (t, 2H); 7.336-7.668 (m, 10H); BC NMR (l25MHz, CDCh) 8: 162.99, 145.35, 
132.23,126.47-128.92,51.04,28.35,27.65,24.27. 
2-0xo-l,2-diphenylethyl-2-chloroacetate (21): Benzoin (0.50g, 2.37 mmol) and 4-
dimethylaminopyridine (0.29 g, 2.37 mmol) were dissolved in dichloromethane (20 mL) 
and the solution was allowed to stir at O°C. Chloroacetyl chloride 20 (0.21 mL, 2.60 
mmol) was added dropwise by syringe. The reaction mixture was then stirred under 
nitrogen at O°C (4h) while monitoring by TLC. Upon completion of the reaction, the 
reaction mixture was dissolved in diethyl ether (100 mL) and washed with water (2 x 90 
mL), 5% aqueous HCI (l x 90 mL), and 5% aqueous sodium bicarbonate (1 x 90mL). 
The diethyl ether layer was separated and dried over anhydrous sodium sulfate. After 
removal of the drying agent by filtration and removal of solvent by rotary evaporation, 
the product chloroacetyl ester 21 was obtained in 95% yield and found to be of 
reasonable purity as evidenced by IH NMR and TLC. Rf: 0.51 (hexane/ethyl acetate, 4:1); 
FTIR 2960.22, 1734.54, 1694.12, 1597.47, 1495.83, 1224.81 em-I; IH NMR (500MHz, 
CDC h) 8: 7.25-7.91 (m, 10H); 6.94 (s, IH); 3.96-4.11 (dd, 2H); BC NMR (125MHz, 
CDCh)8: 192.62,167.91,128.71-134.17,78.75,50.11 
2-0xo-l,2-diphenylethyl-2-azidoacetate (22): 2-oxo-l,2-diphenylethyl-2-chloroacetate 
21 (O.72g, 2.50 mmol) is dissolved in DMF (5 mL). Sodium azide (O.l8g, 2.77 mmol) 
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was then added and the reaction mixture was refluxed (SO°C, oil bath) under nitrogen 
(4h). The reaction mixture was monitored by TLC and when complete, the DMF was 
removed from the reaction mixture by rotary evaporation and then high vacuum. The 
crude oil was purified by flash chromatography on silica gel (hexane/ethyl acetate, 9: 1) to 
obtain the azido ester 22 in 22% yield: Rf: 0.49 (hexane/ethyl acetate, 4: 1); FTIR 
2104.56, 1173.01, 1747.90, 1692.58, 1597.22, 1448.76 cm-l; IH NMR: (500 MHz, 
CDC h) 0: 7.38-7.94 (m, 10H); 6.97 (s, IH); 4.03-4.10 (dd, 2H); I3C NMR (125MHz, 
CDCh) 0: 192.72,167.99,128.44-134.99,78.79,50.09 
2-(azidomethyl)-4,S-diphenyloxazole (23): 2-0xo-l,2-diphenylethyl-2-azidoacetate 22 
(0.14g, 0.48 mmol) was dissolved in glacial acetic acid (XXmL). Ammonium acetate 
(0.57 g, 7.40 mmol) was then added and the reaction mixture was refluxed (l18°C, oil 
bath) under a nitrogen atmosphere (2h). The reaction was monitored by TLC and when it 
was complete, the reaction mixture was dissolved in diethyl ether (100 mL) and washed 
with 7% aqueous sodium hydroxide solution (3 x 100 mL). The diethyl ether layer was 
separated and dried over anhydrous sodium sulfate. Removal of the drying agent by 
filtration and rotary evaporation of the solvent gave a crude oil that was purified by flash 
chromatography on silica gel (hexane:ethylacetate, 8: 1) to provide the azidomethyl 
oxazole 23 in 46% yield: Rf: 0.58 (hexane/ethylacetate, 4: 1); FTIR 2098, 1444.19, 
1569.48,1604.78,1251.13 cm- I; IH NMR (400MHz, CDCh) 0: 4.44 (s, 2H); 7.18-7.59 
(m, 10H; Be NMR (125MHz, CDC h) 0: 157.23, 146.77, 135.52, 126.69-131.80,46.75 
2,4-Dichloro-6-«trimethylsilyl)ethynyl)-1,3,S-triazine (26): Trimethylsilylacetylene 
(0.50 mL, 3.51 mmol) was dissolved in freshly-distilled anhydrous THF (3 mL). n-
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butyllithium (2.20 ml, 3.52 mmol) was then added dropwise by synnge under an 
atmosphere of argon. The reaction mixture was stirred (10 min) under argon atmosphere 
at O°C (ice bath). The lithiotrimethylsilylacetylene 25 was then canulated over a 30 
minute period into a solution of cyanuric chloride (24, 0.65g, 3.52 mmol) dissolved in 
anhydrous THF (4 mL) The reaction mixture was stirred under nitrogen at O°C (ice bath). 
A sample was taken from the reaction mixture and was found to be the product as 
evidenced by lH NMR and l3C NMR: lH NMR (400 MHz, CDCh) 8: 0.00 (s, 9H); I3C 
NMR (l00 MHz, CDCb) 8: 172.93, 161.97, 107.07, 99.77, 0.00 
N2,N4-diisobutyl-6-«trimethylsilyl)ethynyl)-1,3,5-triazine-2,4-diamine (27): 
Isobutylamine (0.73 mL, 7.38 mmol) and diisopropylethylamine (1.53 mL, 8.78 mmol) 
were dissolved THF (2 mL). 2,4-dichloro-6-((trimethylsilyl)ethynyl)-1 ,3,5-triazine 
(above) 26 (0.85g, 3.45 mmol) was then added by syringe and the reaction mixture was 
left to react at room temperature (l2h) while monitoring the progress by TLC. When 
complete, the reaction mixture was dissolved in dichloromethane (150 mL) and then 
washed with water (3 x 80 mL). The dichloromethane layer was separated and dried over 
anhydrous sodium sulfate. Removal of the drying agent by filtration and rotary 
evaporation of the solvent gave a crude solid that was purified by flash chromatography 
on silica gel (hexane/ethyl acetate, 9:1) to afford 27 (1.3%): Rf: 0.79 (hexane/ethyl acetate, 
2:1). lH NMR (400 MHz, CDCh) 8: 0.67-0.69 (d, 12H), 1.57-1.66 (m, IH), 2.91-3.02 (dt, 




((trimethyl-silyl)ethynyl)-l ,3,5-triazine-2,4-diamine (27, 14.5 mg, 0.045 mmol) was 
dissolved in THF (1 mL). Tetrabutylammonium fluoride (0. 59mL, 2.04 mrnol) was then 
added and the reaction mixture was left to react at room temperature (30 min). The 
reaction was monitored by TLC and when complete, the solvent was removed from the 
reaction mixture by rotary evaporation to give a crude solid that was purified by flash 
chromatography on silica gel (hexane/ethyl acetate, 2: 1) to attain 28 in 12% yield. 6-
ethynyl-N2,N4-diisobutyl-1 ,3,5-triazine-2,4-diamine (28): Rf: 0.14 (hexane/ethyl acetate, 
2:1). IH NMR (400 MHz, CDCI3) 0: 0.92-0.94 (d, 12H), 2.15-2.16 (d, 4H), 3.21-3.27 (m, 
2H), 5.29 (s, 1H). 
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DISCUSSION 
In order for P. gingiva lis to become a pathogenic bacterium in the development of 
periodontal disease, it must first become established in the oral cavity. It becomes 
established in the ora) cavity by adhering to select species of oral streptococci8, 
specifically S gordonii. Thus, this interspecies adherence activity represents a 
therapeutic target for controlling periodontal disease. 
Previous studies have shown that adherence of P. gingivalis to streptococci is 
mediated by a protein-protein interaction between Mfa of P. gingivalis and SspB of S 
gordoniP. The active site regions of the SspB protein have been determined7, 15, and a 
peptide composed of these active sites was developed7. This synthetic peptide, named 
the BAR peptide, was proven to be a potent inhibitor of the P. gingivalis-S gordonii 
interaction7. In this study, we developed several small organic click molecules 
mimicking certain characteristics of the BAR peptide, with the ultimate goal of 
developing a compound that is an equal or greater inhibitor of the P. gingivalis-S 
gordonii interaction. 
The six click components that have been developed will be tested for their 
bioactivity. The first bioactivity assessment will be using a series of in vitro binding 
inhibition assays. This test will not only assess the bioactivity of the compounds, but will 
also assess whether these compounds are toxic to the proteins. The Sgordonii and P. 
gingivalis will be grown in the presence of increasing concentrations of the inhibitor and 
comparing growth with that of bacteria grown in medium alone. It is not anticipated that 
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the click molecules will be toxic to the bacteria, however if they are, they could represent 
new antibiotics. The second bioactivity assessment will measure the inhibition of P. 
gingivalis-S gordonii biofilm formation using an established flow cell biofilm culture 
system. The mimetic compounds will be pre-incubated with P. gingivalis cells at varying 
concentrations prior to inoculation into the flow cell chamber containing the established 
S gordonii cells. The P. gingivalis-Sgordonii biofilms will be visualized using a 
confocal laser scanning microscope, and the number of microcolonies that form per 
microscope field and the depth of each microcolony will be recorded and analyzed using 
the COMSTAT program. Lastly, the active compounds will be tested for in vivo efficacy 
using the Baker mouse model of periodontitis. 
If the initial bioactivity assessments do not show significant inhibition at 
reasonably low concentrations, the basic scaffolds are flexible, and can be quickly 
modified to improve activity. There are several areas in which the core structures can be 
modified. Firstly, every appendage to both the oxazole and triazine structures can be 
altered in the type of hydrophobic appendage attached, a basic appendage could be 
added, or a charged functional group could be included. Secondly, both the oxazole and 
triazine structures produce only planar molecules. Depending on the results of the 
bioactivity assessments, it might be beneficial to change one or both of these core 
structures to a molecule that has stereochemistry and provides 3-dimensionality. There 
are many different options in which we can modify these initial compounds in order to 
optimize inhibition. 
The benefits that will stem from this study are both numerous and diverse. Not 
only will this study help in a biological sense for the treatment of periodontal diseases, 
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but this study also will help in the progression of the "click-chemistry" movement. 
Currently, click chemistry is still a relatively new idea, and many "click-readied" 
building units and "click products" are not yet commercially available. Therefore, any 
new azide or acetylene molecules that can be created will help build the library of click 
building units. The more known azide and acetylene compounds prepared, and ideally 
commercially available azide and acetylene compounds, the quicker new pharmaceutical 
compounds can be developed. 
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